Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 8/20 | 0.45 |
| ▸ | TLR9 | Q9NR96 | 9/20 | 0.45 |
| ▸ | TLR7 | Q9NYK1 | 9/20 | 0.45 |
| ▸ | HTR1A | P08908 | 3/20 | 0.36 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.33 |
| ▸ | BMPR1A | P36894 | 1/20 | 0.33 |
| ▸ | ACVR1B | P36896 | 1/20 | 0.33 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23628818 | 0.90 | TLR8 (0.50) | TLR8TLR9TLR7HTR1AACVR1 | |
| SCHEMBL23760699 | 0.85 | TLR8 (0.46) | TLR8TLR9TLR7ACVR1HRH1 | |
| SCHEMBL16633393 | 0.83 | TLR9 (0.48) | TLR8TLR9TLR7HTR1AACVR1 | |
| SCHEMBL16633390 | 0.83 | TLR9 (0.48) | TLR8TLR9TLR7HTR1AACVR1 | |
| SCHEMBL23760686 | 0.82 | TLR8 (0.45) | TLR8TLR9TLR7ACVR1 | |
| SCHEMBL23760707 | 0.81 | TLR8 (0.51) | TLR8TLR9TLR7HTR1AKDM4E | |
| SCHEMBL23628790 | 0.81 | TLR8 (0.51) | TLR8TLR9TLR7HTR1AKDM4E | |
| SCHEMBL23760736 | 0.81 | TLR8 (0.40) | TLR8TLR9TLR7HRH1HRH3 | |
| SCHEMBL23760712 | 0.81 | TLR8 (0.40) | TLR8TLR9TLR7HRH1HRH3 | |
| SCHEMBL23760716 | 0.77 | TLR8 (0.62) | TLR8TLR9TLR7KDM4EHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253575-A1 | PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | HOFFMANN-LA ROCHE INC. (US) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253575-A1 | PYRROLIDINE AMINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | ARG1, PRMT1, PADI1 | TLR8 1800/4885TLR9 308/4885TLR7 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.